PF-AtlasКлинические испытания › NCT07245407

A Translational Study for Phenotyping and Endotyping Chinese Patients With NCFBE

Participant Follow-up · Не указано

ID реестра
NCT07245407
Фаза
Не указано
Статус
Набор идет
Препарат / вмешательство
Participant Follow-up
Спонсор
AstraZeneca
Начало
2025-10-27
Набор участников
320
Центры
38

Об исследовании

Non-cystic fibrosis bronchiectasis (NCFBE) is a chronic respiratory disease characterized by a clinical syndrome of chronic productive cough and recurrent respiratory infections in the presence of abnormal and permanent dilation of the bronchi. Recent epidemiological studies have clearly shown that the prevalence and incidence of NCFBE are quickly rising both in high- and low-income countries. With the increase of prevalence, bronchiectasis brings huge medical and economic burden to the society. In this study, the investigator will perform biomarker assessments and multi-omics analysis on NCFBE patients and healthy participants in China to validate the link of disease pathways to pathophysiological features and uncover the molecular endotypes behind clinical phenotypesof Chinese patients with NCFBE.

Открыть NCT07245407 на ClinicalTrials.gov →

Связанные материалы

Медицинская оговорка. Эта страница обобщает публичные данные исследования NCT07245407 только для информации. Это не медицинская рекомендация, не одобрение и не предложение участия. Проверяйте детали на ClinicalTrials.gov и у квалифицированного врача.